Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Oxford-Astrazeneca Covid-19 vaccine trial volunteers kept in dark about dosing error: Report

Ruchika Sharma2 Feb 2021 3:50 PM IST

London: About 1,500 of the initial volunteers in a late-stage clinical trial of the Oxford/AstraZeneca Covid-19 vaccine were given the wrong dose, but...

Roche Itovebi recommended by CHMP for EU approval for PIK3CA-mutated, ER-positive, HER2-negative, advanced breast cancer

Roche obtains CE mark for SARS-CoV-2 Rapid Antigen Test Nasal

Ruchika Sharma2 Feb 2021 2:30 PM IST

Besides being less invasive, the test also provides patients with the option to self-collect their nasal sample under the supervision of a healthcare...

Bharat Biotech welcomes budget allocation of Rs 35000 crore for Covid vaccine

Ruchika Sharma2 Feb 2021 12:36 PM IST

Hyderabad: Covaxin maker Bharat Biotech on Monday described as "far reaching" initiative the allocation of Rs 35,000 crore for Covid-19 vaccination in...

FICCI names Dr GSK Velu as new Chairman for TN State Council

Ruchika Sharma2 Feb 2021 11:48 AM IST

New Delhi: Renowned healthcare entrepreneur, Dr. G.S.K. Velu has been appointed as the Chairperson of Federation of Indian Chambers of Commerce...

Wockhardt reports PAT at Rs 15 crore in Q3

Ruchika Sharma2 Feb 2021 10:00 AM IST

Mumbai: Pharmaceutical and Biotechnology major, Wockhardt Limited, reported the company's third Quarter Results for Financial Year...

Cutis Biotech PIL against Serum Institute usage of Covishield trademark rejected by Pune court

Ruchika Sharma1 Feb 2021 5:45 PM IST

While rejecting the application against Serum Institute of India the court also observed that Cutis Biotech (the plaintiff) has not approached the...

Takeda concludes sale of Select OTC, Non-Core Assets to Hypera Pharma

Ruchika Sharma1 Feb 2021 1:23 PM IST

Takeda intends to use the proceeds from the sale to reduce its debt and accelerate deleveraging towards its target of 2x net debt/adjusted EBITDA...

Novartis to provide manufacturing capacity for Pfizer-BioNTech COVID-19 vaccine production

Ruchika Sharma1 Feb 2021 12:33 PM IST

Basel: Pharma major, Novartis, has recently announced that the company has signed an initial agreement to leverage its manufacturing capacity and...

Granules India secures USFDA approval for Potassium Chloride Oral Solution

Ruchika Sharma1 Feb 2021 11:19 AM IST

Hyderabad: Granules India Limited announced that the US Food & Drug Administration (US FDA) has approved the Abbreviated New Drug...

Healthcare focused SaaS startup Zealthix raises USD 1.1 million in seed round

Hester Biosciences net profit rises 8 percent at Rs 13 crore in Q3

Ruchika Sharma1 Feb 2021 10:00 AM IST

The company''s developmental activities are ongoing for the human COVID-19 vaccine with IIT Guwahati, it added.

Serum Institute seeks nod to conduct local trial of Novavax COVID-19 vaccine

Ruchika Sharma31 Jan 2021 11:00 AM IST

New Delhi: The Serum Institute of India (SII), the world's biggest vaccine maker, has applied to local authorities to conduct a small domestic trial...

AstraZeneca discontinues Phase 3 trial of prostate cancer drug Truqap

AstraZeneca chief says COVID-19 vaccine supply may meet, even outstrip demand in India by Q3

Ruchika Sharma31 Jan 2021 10:00 AM IST

New Delhi: The supply of vaccines for Covid-19 may meet up or even outstrip the demand in India by the third quarter of this year, given the number of...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok